Exemestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the conversion of cholesterol to pregnenolone and the peripheral aromatization of androgenic precursors into estrogens. Exemestane is a drug which is used for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. FDA approval was in October 2005.
SynZeal offers allExemestane related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Exemestane related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.